Related Experiment Videos
[Benign myoclonic epilepsy in infant]
J M Prats-Viñas1, C Garaizar, C Ruiz-Espinoza
1Unidad de Neuropediatría; Hospital de Cruces, Barakaldo, 48903, Espana. med002206@nacom.es
Revista De Neurologia
|May 22, 2002
Summary
Benign myoclonic epilepsy of infancy can have varied outcomes, with some children experiencing developmental challenges and later-onset seizures. Eyelid myoclonia at onset does not predict intellectual development or treatment response.
Area of Science:
- Neurology
- Pediatric Neurology
- Epileptology
Background:
- Benign myoclonic epilepsy of infancy (BMEI) is a rare epilepsy syndrome.
- Understanding its long-term prognosis and clinical spectrum is crucial for accurate diagnosis and management.
Observation:
- This study reviewed literature and presented seven cases of BMEI diagnosed using Dravet's criteria.
- Three males and four females were included, with follow-up ranging from 6 to 26 years.
Findings:
- Three patients (43%) showed unfavorable intellectual and behavioral development.
- Three patients experienced later-onset generalized seizures, including tonic-clonic seizures and absence status epilepticus.
- Eyelid myoclonia, occurring with limb and head myoclonic seizures, was observed in four patients but did not correlate with prognosis or treatment response.
Implications:
- BMEI may present with a broader spectrum of outcomes than previously recognized.
- The presence of eyelid myoclonia does not reliably predict developmental trajectory or treatment efficacy.
- Further research is needed to elucidate the long-term prognosis and identify potential prognostic markers in BMEI.